Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
GH3 |
Rat pituitary gland neoplasm cancer cell line (somatotropic) | ATCC ® ATCC CCL82.1 | Rat | brain | cell line | adherent | plasmid | Metafectene PRO | publication | G. Brigantea et al., Mol. and Cell. Endocrinology, 2019, 482: 37–44, doi.org/10.1016/j.mce.2018.12.005 | Link | ||
H357 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | N. Düzgünes et al., Methods in Enzymology, 2012, 509, DOI: 10.1016/B978-0-12-391858-1.00018-6 | ||||
H413 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | N. Düzgünes et al., Methods in Enzymology, 2012, 509, DOI: 10.1016/B978-0-12-391858-1.00018-6 | ||||
H9C2 |
Rat cardiomyocyte cell line | ATCC CRL-1446 | Rat | muscle | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | H. A. Nicolas et al., cells, 2020, 9:2388, doi:10.3390/cells9112388 | Link | |
H9c2 |
Rat cardiomyocyte cell line | ATCC CRL-1446 | Rat | muscle | cell line | adherent | plasmid | Metafectene PRO | publication | I. Fortuin, Master Thesis, 2013, University of the Western Cape | Link | ||
H9c2 |
Rat cardiomyocyte cell line | ATCC CRL-1446 | Rat | muscle | cell line | adherent | plasmid | Metafectene PRO | publication | W. Khan, PhD Thesis, 2020, UiT The Arctic University of Norway | Link | ||
HaCaT |
Human keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
HaCaT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | W. Xiao et al., Free Radical Biology and Medicine, 2013, 65: 70–77, doi.org/10.1016/j.freeradbiomed.2013.06.010 | ||||
HaCaT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | L. Stixová et al., Life, 2021, 11, 669, doi.org/10.3390/life11070669 | Link | |||
hADMC |
Human primary adipose-derived mast cells | Human | immune system | primary cell | plasmid | Metafectene PRO | publication | M. Motaghed et al., J. Immuntherapy of Cancer, 2021, 9(Suppl 2): A1–A1052, doi.org/10.1136/jitc-2021-SITC2021.220 | Link | ||||
hAEC |
Human aortic endothelial cells | Human | vasculature | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
HAT7 |
Dental epithelial cell line originating from a cervical loop epithelium of a rat incisor | Rat | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | S.-J. Park, PhD Thesis, 2017, Seoul National University | Link | |||
HAT7 |
Dental epithelial cell line originating from a cervical loop epithelium of a rat incisor | Rat | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | H.-K. Lee, PhD Thesis, 2015, Seoul National University | Link | |||
HAT7 |
Dental epithelial cell line originating from a cervical loop epithelium of a rat incisor | Rat | digestive organs | cell line | plasmid | Metafectene PRO | publication | H.-K. Lee et al., J. Biol. Chem., Jun 2015; 290: 14740 - 14753 | Link | ||||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HCC-44 |
Human lung adenocarcinoma cell line | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Berrout et al., Nature Communications, 2017,8: 947, DOI: 10.1038/s41467-017-00983-w | Link | |||
HCC-515 |
Human lung adenocarcinoma cell line | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Berrout et al., Nature Communications, 2017,8: 947, DOI: 10.1038/s41467-017-00983-w | Link | |||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | M. Arechederra et al., J. Biol. Chem., Feb 2015; 290: 4383 - 4397 | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. P. Bendeck, Dissertation, 2016, Universidad Complutense de Madrid | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. Priego et al., Oncotarget, 2016, 7 (29): 45060-45078 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | D. Flügel et al., Blood, 2012, 119(5):1292‐1301, doi:10.1182/blood-2011-08-375014 | Link |